↓ Skip to main content

Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19

Overview of attention for article published in Frontiers in immunology, December 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
Published in
Frontiers in immunology, December 2021
DOI 10.3389/fimmu.2021.798276
Pubmed ID
Authors

Sibylle C. Mellinghoff, Kanika Vanshylla, Christine Dahlke, Marylyn M. Addo, Oliver A. Cornely, Florian Klein, Thorsten Persigehl, Jan Rybniker, Henning Gruell, Paul J. Bröckelmann

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 13%
Student > Bachelor 6 13%
Researcher 4 9%
Student > Ph. D. Student 4 9%
Other 2 4%
Other 5 11%
Unknown 20 43%
Readers by discipline Count As %
Medicine and Dentistry 15 32%
Nursing and Health Professions 2 4%
Arts and Humanities 1 2%
Environmental Science 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 4%
Unknown 25 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2022.
All research outputs
#14,795,067
of 25,392,582 outputs
Outputs from Frontiers in immunology
#12,935
of 31,541 outputs
Outputs of similar age
#224,629
of 513,657 outputs
Outputs of similar age from Frontiers in immunology
#637
of 1,510 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,657 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 1,510 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.